Li Chen, Executive Director & CEO at Hua Medicine, discusses the Chinese biotech firm's growth plans exclusively on "Bloomberg: The China Show" following the company's first half results. (Source: Bloomberg)
Li Chen, Executive Director & CEO at Hua Medicine, discusses the Chinese biotech firm's growth plans exclusively on "Bloomberg: The China Show" following the company's first half results. (Source: Bloomberg)
Lire l’article complet sur le site source
Bloomberg — Markets (EN)